Insider buying last 90 days
No open-market insider purchases were filed for CVSA in the last 90 days.
From Form 4 filings, dated to when each was filed.
Oct 12 close
CEO Stephen Beard sold shares this week, with transactions of $610,303.59 and $474,416 under a Rule 10b5-1 trading plan, reducing his ownership by 0.98% and 0.76% respectively. Separately, BMO Capital Markets lowered its price target on Adtalem to $145 from $148 while maintaining an "outperform" rating, noting the company exceeded its quarterly earnings expectations. Analysts overall carry a consensus "Hold" rating, with a consensus target price cited at $151.67 in one report.
CVSA closed at $128.87, down 0.4%, sitting above both its 50-day average of $128.36 and its 200-day average of $118.30, with the shorter average above the longer one. The GekkoIndex reads 53.6, placing the stock in the Neutral zone, down from a reading five points higher recently. Gekko Fair Value stands at $177.81, putting the current price 27.5% below that level.
Adtalem's next earnings report is set for 29 October 2026 after the close, 17 days away and within a typical 20-trading-day holding window; the prior quarter's actual EPS of $2.09 beat the $1.89 estimate and the stock reacted with a 9.4% move, part of a streak of 8 beats in 8 quarters with an average absolute reaction of 12.8%. Seasonality over the next 20 trading days has averaged a 2.4% gain across 5 years, rising in 3 of them. Analyst coverage from 4 firms shows 3 buy and 1 hold ratings, with a consensus target of $158.75 implying 23.2% upside.
Written by AI from the Oct 12, 2026 close and checked automatically against the figures on this page.
Adtalem Global Education scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Above 50 and 200-day
Close $128.87 is above the 50-day ($128.36) and 200-day ($118.30) averages, and the 50-day is above the 200-day.
See the chart53.6, Neutral
Reading 53.6 is in the Neutral zone.
See the GekkoIndex27.5% below
Price is 27.5% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 17 days
Reports on Oct 29, 2026, 17 days away — inside a typical 20-trading-day hold.
See earnings+2.4% on average
From this point in the calendar, the next 20 trading days averaged +2.4% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Adtalem Global Education closed at $128.87 on Oct 12, 2026, −10.3% over the past year, inside a 52-week range of $86.97 to $156.26.
Use the left and right arrow keys to read daily values.
Put CVSA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Adtalem Global Education operates in the higher education space, serving students who are pursuing academic credentials in nursing, health care, veterinary science, and related fields. It has built recognition around preparing people for careers in nursing and in medical and veterinary work.
Its business is split into three segments. Chamberlain centers on coursework tied to nursing and other health-related professions, offering both full degrees and shorter non-degree programs. Walden runs online programs covering areas like nursing, counseling, education, psychology, business, social work, public health, criminal justice, public administration, human services, and public policy, with options spanning certificates through doctoral-level study. The Medical and Veterinary segment handles degree and non-degree instruction aimed at students entering medicine or veterinary science after their undergraduate years.
The business traces back to 1973, when Dennis J. Keller and Ronald L. Taylor founded it, and its main offices are in Chicago, Illinois. Shares of the company trade on the NYSE under the ticker CVSA.
Adtalem Global Education’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 53.6, in the Neutral zone, down 6.8 points over five sessions.
Down 6.8 points over five sessions, from the Accumulation zone.
Reading for Oct 12, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 2 | Too few readings yet | |||
| Accumulation | 36 | +2.5% | +6.3% | ||
| Neutral (current zone) | 103 | +0.3% | +1.3% | ||
| Distribution | 2 | Too few readings yet | |||
| Selling | 0 | Not available | |||
Average CVSA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Adtalem Global Education trades 27.5% below Gekko Fair Value of $177.81, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Adtalem Global Education shares are worth, recalculated every trading day.
$177.81
Gekko Fair Value, Oct 10, 2026
27.5% Undervalued
At the end of Aug 2026 the price was 30.6% below the estimate.
No open-market insider purchases were filed for Adtalem Global Education, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CVSA in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CVSA were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Adtalem Global Education has been buying back its own shares.
From company filings.
Adtalem Global Education reports on Oct 29, 2026, after the close (17 days away), and beat the EPS estimate in 8 of its last 8 reports.
Oct 29, 2026
Expected after the close, 17 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 6, 2026 | $2.09 est $1.89 | $501.4M est $486.6M | +9.4% |
| May 7, 2026 | $1.98 est $1.73 | $487.0M est $474.0M | +16.0% |
| Jan 28, 2026 | $2.43 est $2.19 | $503.4M est $488.7M | −6.5% |
| Oct 30, 2025 | $1.75 est $1.58 | $462.3M est $452.3M | −30.5% |
| Aug 7, 2025 | $1.66 est $1.53 | $457.1M est $440.9M | +1.7% |
| May 8, 2025 | $1.92 est $1.65 | $466.1M est $446.8M | +18.7% |
| Jan 30, 2025 | $1.81 est $1.37 | — | +7.3% |
| Oct 29, 2024 | $1.29 est $1.13 | — | +12.0% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Adtalem Global Education is $158.75, +23.2% from the last close, from 4 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 4 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 5 | BMO Capital | $145 | +12.5% |
| Oct 1 | Barrington | $175 | +35.8% |
| Sep 15 | Jefferies | $175 | +35.8% |
| Sep 3 | Truist Financial | $140 | +8.6% |
| Aug 17 | Jefferies | $175 | +35.8% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Oct 10, Adtalem Global Education averaged +2.4% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +0.7% | 2 of 5 |
| Next 10 trading days | +1.4% | 4 of 5 |
| Next 15 trading days | +1.9% | 4 of 5 |
| Next 20 trading days | +2.4% | 3 of 5 |
| Next 30 trading days | −0.3% | 3 of 5 |
For scale, CVSA’s typical 20-trading-day move in either direction is about 6.8%.
Adtalem Global Education’s market cap is $4.39B, with a P/E ratio of 17.4 and revenue of $1.95B over the last twelve months.
Coverage of Adtalem Global Education this week reads neutral: 1 positive, 2 neutral and 1 negative headlines.
Adtalem Global Education’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| BKNGBooking | Accumulation | 28.5% below |
| EXPEExpedia | Neutral | 2.6% below |
| SCIService Corporation International | Accumulation | 2.1% above |
| LTHLife Time | Accumulation | 15.7% below |
| ANDGAndersen | Neutral | 8.0% below |
| HRBH&R Block | Neutral | 38.0% below |
A peer links to its own page where one exists.
Adtalem Global Education’s market cap is $4.39B at the Oct 12, 2026 close of $128.87, with 33.86M shares outstanding. The shares trade on a P/E ratio of 17.4.
The consensus analyst 12-month price target for Adtalem Global Education is $158.75, +23.2% from the last close. Of the 4 firms that rated the stock in the last 90 days, 3 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Adtalem Global Education is undervalued: the Oct 12, 2026 close of $128.87 is 27.5% below Gekko Fair Value of $177.81. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Adtalem Global Education is expected to report on Oct 29, 2026, after the market closes (17 days away). Analysts expect earnings of $1.83 per share on revenue of $488.5M. Adtalem Global Education beat the earnings estimate in 8 of its last 8 reports, moving 12.8% on average across the report.
Adtalem Global Education’s 52-week high is $156.26 and its 52-week low is $86.97; it closed at $128.87 on Oct 12, 2026, −10.3% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (earnings risk). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.